NCT06948955 Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors Status AVAILABLE Phase N/A
NCT06915766 Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis Status AVAILABLE Phase N/A
NCT04996875 (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis Status RECRUITING Phase PHASE2